4/A: Balchem Corp Director Rigaud Corrects Stock Vesting Period in Amended SEC Filing
SEC Filing
Olivier Rigaud, a director at Balchem Corp, filed an amended SEC Form 4/A to correct the vesting period of restricted stock from three years to one year.
Summary
- Olivier Rigaud, a director at Balchem Corp, filed an amended SEC Form 4/A on April 11, 2025, to correct an error in the original filing from February 14, 2025.
- The amendment clarifies that the restricted stock vests one year following the grant date, not three years as initially reported.
- The transaction date for the acquisition of 980 shares of common stock was February 12, 2025, at a price of $0.
- Following the transaction, Rigaud beneficially owns 1,520 shares of Balchem Corp common stock.
Sentiment
Score: 7
Explanation: The document is a routine correction of a previous filing, indicating standard corporate governance practices. The sentiment is neutral to slightly positive as it reflects transparency and adherence to regulatory requirements.
Industry Context
This filing is a routine disclosure related to insider transactions and corrections, and doesn't necessarily reflect broader industry trends.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Transaction date for the acquisition of 980 shares of common stock. |
| 02/14/2025 | Date of original Form 4 filing with incorrect vesting period. |
| 04/11/2025 | Date of amended Form 4/A filing correcting the vesting period. |
Keywords
Form 4/A, Balchem Corp, BCPC, Olivier Rigaud, Director, Stock Vesting, Restricted Stock, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.